C81.2 Catégorie · précision supplémentaire requise Mixed cellularity Hodgkin lymphoma
ICD-10-CM C81.2 identifies “Mixed cellularity Hodgkin lymphoma” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 2: Neoplasms
Instructions du code
Inclusion terms1
Mixed cellularity classical Hodgkin lymphoma
Instructions des niveaux supérieurs
Chapitres 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C81 · Hodgkin lymphoma
Excludes 11
personal history of Hodgkin lymphoma (Z85.71)
Codes plus précis
C81.20Mixed cellularity Hodgkin lymphoma, unspecified siteCode facturable et spécifiqueC81.21Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neckCode facturable et spécifiqueC81.22Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodesCode facturable et spécifiqueC81.23Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodesCode facturable et spécifiqueC81.24Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limbCode facturable et spécifiqueC81.25Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limbCode facturable et spécifiqueC81.26Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodesCode facturable et spécifiqueC81.27Mixed cellularity Hodgkin lymphoma, spleenCode facturable et spécifiqueC81.28Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sitesCode facturable et spécifiqueC81.29Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sitesCode facturable et spécifiqueC81.2AMixed cellularity Hodgkin lymphoma, in remissionCode facturable et spécifiqueRéférences de l’index officiel
Références de l’index officiel (2)
Lymphoma(of) (malignant) (2)
- Lymphoma(of) (malignant) › Hodgkin › mixed cellularity(classical)Index des maladies
- Lymphoma(of) (malignant) › Hodgkin › mixed cellularity classicalIndex des maladies
Historique
Historique du code
Dernière modification enregistrée · FY2017
ModifiéInchangé
FY2017
En vigueur dès le
- Libellé modifié
- Instructions du code modifiées
Mixed cellularity Hodgkin lymphoma
Ancien libellé: Mixed cellularity classical Hodgkin lymphoma
Catégorie — choisir un code plus précis
CDC/NCHS · FY2017Toutes les éditions (19)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2016 | 2015-10-01 | Première observation |
| FY2017 | 2016-10-01 | Libellé modifié · Instructions du code modifiées |
| FY2018 | 2017-10-01 | Aucun changement tabulaire |
| FY2019 | 2018-10-01 | Aucun changement tabulaire |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Aucun changement tabulaire |
| FY2025 · 04-01 | 2025-04-01 | Aucun changement tabulaire |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.